SEC Form 4 · accession 0001193805-26-000929
IMMUNIC, INC. · IMUX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joerg Neermann
Director
Period of report
Jul 5, 2026
Accepted (ET)
Jul 7, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001280776
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $14.80 | Jul 5, 2026 | A | 25,370 | A | — | Jul 5, 2036 | Common Stock | 25,370 | 25,370 | D |
Explanation of responses
- F1The option vests in monthly increments over a period of one year from the grant date.